These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 37726803)
1. Transcriptome profiling of patient-derived tumor xenografts suggests novel extracellular matrix-related signatures for gastric cancer prognosis prediction. Deng Z; Guo T; Bi J; Wang G; Hu Y; Du H; Zhou Y; Jia S; Xing X; Ji J J Transl Med; 2023 Sep; 21(1):638. PubMed ID: 37726803 [TBL] [Abstract][Full Text] [Related]
2. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
3. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer. Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725 [TBL] [Abstract][Full Text] [Related]
4. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature. Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X Front Immunol; 2021; 12():651033. PubMed ID: 34054812 [TBL] [Abstract][Full Text] [Related]
5. Development and validation of a hypoxia- and mitochondrial dysfunction- related prognostic model based on integrated single-cell and bulk RNA sequencing analyses in gastric cancer. Li Y; Cui Y; Wang Z; Wang L; Yu Y; Xiong Y Front Immunol; 2024; 15():1419133. PubMed ID: 39165353 [TBL] [Abstract][Full Text] [Related]
6. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer. Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K Front Immunol; 2022; 13():947802. PubMed ID: 36405735 [TBL] [Abstract][Full Text] [Related]
7. Progressive and Prognostic Performance of an Extracellular Matrix-Receptor Interaction Signature in Gastric Cancer. Yang X; Chen L; Mao Y; Hu Z; He M Dis Markers; 2020; 2020():8816070. PubMed ID: 33178362 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Implications of Novel Gene Signatures in Gastric Cancer Microenvironment. Sun M; Qiu J; Zhai H; Wang Y; Ma P; Li M; Chen B Med Sci Monit; 2020 Aug; 26():e924604. PubMed ID: 32740646 [TBL] [Abstract][Full Text] [Related]
9. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer. Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268 [No Abstract] [Full Text] [Related]
10. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer. Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183 [TBL] [Abstract][Full Text] [Related]
11. Construction of a hypoxia-immune-related prognostic panel based on integrated single-cell and bulk RNA sequencing analyses in gastric cancer. Deng C; Deng G; Chu H; Chen S; Chen X; Li X; He Y; Sun C; Zhang C Front Immunol; 2023; 14():1140328. PubMed ID: 37180146 [TBL] [Abstract][Full Text] [Related]
12. Immune infiltration and prognosis in gastric cancer: role of NAD+ metabolism-related markers. Xing Y; Zhang Z; Gao W; Song W; Li T PeerJ; 2024; 12():e17833. PubMed ID: 39099656 [TBL] [Abstract][Full Text] [Related]
13. Overall survival prediction of gastric cancer using the gene signature of CT-detected extramural venous invasion combined with M2 macrophages infiltration. Yang H; Gou X; Feng C; Zhang Y; Sun B; Peng P; Wang Y; Hong N; Ye Y; Cheng J; Gao B J Transl Med; 2024 Sep; 22(1):829. PubMed ID: 39252063 [TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes. Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791 [No Abstract] [Full Text] [Related]
15. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer. Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405 [TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients. Liu G; Ma JY; Hu G; Jin H PLoS One; 2021; 16(7):e0254368. PubMed ID: 34252149 [TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of cancer-associated fibroblast signature in gastric cancer. Zhao Z; Mak TK; Shi Y; Li K; Huo M; Zhang C Heliyon; 2023 Sep; 9(9):e19217. PubMed ID: 37809716 [TBL] [Abstract][Full Text] [Related]
18. A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients. Cao W; Zhou W; Li M; Zhang Z; Zhang X; Yang K; Yang S; Cao G; Chen B; Xiong M Front Immunol; 2022; 13():951135. PubMed ID: 36483555 [TBL] [Abstract][Full Text] [Related]
19. Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function. Wang SY; Wang YX; Shen A; Yang XQ; Liang CC; Huang RJ; Jian R; An N; Xiao YL; Wang LS; Zhao Y; Lin C; Wang CP; Yuan ZP; Yuan SQ Eur J Med Res; 2024 Mar; 29(1):180. PubMed ID: 38494472 [TBL] [Abstract][Full Text] [Related]
20. COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencing. Chen M; Zhu X; Zhang L; Zhao D BMC Med Genomics; 2023 Sep; 16(1):220. PubMed ID: 37723519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]